Cargando…

Corrigendum: Targeted therapy in cardiovascular disease: A precision therapy era

Detalles Bibliográficos
Autores principales:	Xu, Mengda, Zhang, Kailun, Song, Jiangping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937158/ https://www.ncbi.nlm.nih.gov/pubmed/36817135 http://dx.doi.org/10.3389/fphar.2023.1145460

Ejemplares similares

Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era
por: Xu, Mengda, et al.
Publicado: (2021)

Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
por: Wang, Xing, et al.
Publicado: (2023)

Biomarkers of Neurodegeneration and Precision Therapy in Retinal Disease
por: Micera, Alessandra, et al.
Publicado: (2021)

Corrigendum: Anakinra Therapy for Non-cancer Inflammatory Diseases
por: Cavalli, Giulio, et al.
Publicado: (2019)

Corrigendum: Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy
por: Zhou, Yihui, et al.
Publicado: (2021)

Corrigendum: R-carvedilol, a potential new therapy for Alzheimer’s disease
por: Yao, Jinjing, et al.
Publicado: (2023)

Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy
por: Bhagwat, Geeta S., et al.
Publicado: (2023)

Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
por: Hampel, Harald, et al.
Publicado: (2019)

Corrigendum: Research advances in drug therapy of endometriosis
por: Shi, Jianyou, et al.
Publicado: (2023)

Corrigendum: Research advances in drug therapy of endometriosis
por: Shi, Jianyou, et al.
Publicado: (2023)

Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus
por: Zhu, Wei, et al.
Publicado: (2019)

LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
por: Li, Zining, et al.
Publicado: (2022)

Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine
por: Mei, Chao, et al.
Publicado: (2023)

A Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease
por: Fang, Lu, et al.
Publicado: (2017)

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2023)

CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
por: Lopes-Pacheco, Miquéias
Publicado: (2020)

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
por: Biswas, Mohitosh, et al.
Publicado: (2022)

Corrigendum: Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine
por: Guin, Debleena, et al.
Publicado: (2020)

Dual-Responsive Core Crosslinking Glycopolymer-Drug Conjugates Nanoparticles for Precise Hepatocarcinoma Therapy
por: Wu, Jing, et al.
Publicado: (2018)

Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
por: Chandrasekharan, Karthik, et al.
Publicado: (2020)

Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine
por: Lupo, Gabriella, et al.
Publicado: (2017)

Precision caffeine therapy for apnea of prematurity and circadian rhythms: New possibilities open up
por: Dai, Hao-Ran, et al.
Publicado: (2022)

Redefining the polypill: pros and cons in cardiovascular precision medicine
por: Birla, Siddharth, et al.
Publicado: (2023)

Gasdermin E: A Prospective Target for Therapy of Diseases
por: Liao, Xiu-Xiu, et al.
Publicado: (2022)

Corrigendum: Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy
por: Luo, Hao-Yun, et al.
Publicado: (2023)

Corrigendum: The Role of High-Content Complex Dietary Fiber in Medical Nutrition Therapy for Gestational Diabetes Mellitus
por: Wang, Hong-Kun, et al.
Publicado: (2021)

Atorvastatin Therapy Modulates Telomerase Activity in Patients Free of Atherosclerotic Cardiovascular Diseases
por: Strazhesko, Irina D., et al.
Publicado: (2016)

Probiotic Supplementation for Rheumatoid Arthritis: A Promising Adjuvant Therapy in the Gut Microbiome Era
por: Ferro, Margarida, et al.
Publicado: (2021)

Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cells
por: Ramachandra, Durrgah L., et al.
Publicado: (2015)

Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States
por: Iglesias-Lopez, Carolina, et al.
Publicado: (2020)

Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update
por: Cenini, Giovanna, et al.
Publicado: (2019)

Prostaglandin Reductase 1 as a Potential Therapeutic Target for Cancer Therapy
por: Wang, Xing, et al.
Publicado: (2021)

Optimizing Antimicrobial Therapy by Integrating Multi-Omics With Pharmacokinetic/Pharmacodynamic Models and Precision Dosing
por: Yow, Hui-Yin, et al.
Publicado: (2022)

Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy
por: Oliveira-Giacomelli, Ágatha, et al.
Publicado: (2018)

Aging, Cell Senescence, the Pathogenesis and Targeted Therapies of Osteoarthritis
por: Zhang, Xin-Xin, et al.
Publicado: (2021)

Gender Disparity in Cardiovascular Disease in the Era of Precision Medicine
por: Hosseini, Naeimeh, et al.
Publicado: (2023)

Emerging Therapies in CLL in the Era of Precision Medicine
por: Iyer, Prajish, et al.
Publicado: (2023)

Targeting neurosteroidogenesis as therapy for PTSD
por: Pinna, Graziano
Publicado: (2014)

Nanotechnology for Targeted Therapy of Atherosclerosis
por: Hossaini Nasr, Seyedmehdi, et al.
Publicado: (2021)

Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease
por: Nusca, Annunziata, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s5mpmltcn2f4o3avbt5rra4tm5